2022
DOI: 10.1093/neuonc/noac166
|View full text |Cite
|
Sign up to set email alerts
|

Combined molecular subtyping, grading, and segmentation of glioma using multi-task deep learning

Abstract: Background Accurate characterization of glioma is crucial for clinical decision making. A delineation of the tumor is also desirable in the initial decision stages but is time-consuming. Previously, deep learning methods have been developed that can either non-invasively predict the genetic or histological features of glioma, or that can automatically delineate the tumor, but not both tasks at the same time. Here, we present our method that can predict the molecular subtype and grade, while s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
33
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 59 publications
(52 citation statements)
references
References 39 publications
2
33
0
Order By: Relevance
“…Van der Voort et al developed an algorithm with data from 1,508 patients which simultaneously segments, grades, and genotypes of glioma in terms of IDH mutation and 1p/19q codeletion. The model reached accuracies of 80%–90% in an entirely independent dataset of 240 patients, which were similar to those reached in the development set, evidencing the robustness of the algorithm against scanner, site, and protocol variations 106 …”
Section: Discussionsupporting
confidence: 64%
See 1 more Smart Citation
“…Van der Voort et al developed an algorithm with data from 1,508 patients which simultaneously segments, grades, and genotypes of glioma in terms of IDH mutation and 1p/19q codeletion. The model reached accuracies of 80%–90% in an entirely independent dataset of 240 patients, which were similar to those reached in the development set, evidencing the robustness of the algorithm against scanner, site, and protocol variations 106 …”
Section: Discussionsupporting
confidence: 64%
“…The model reached accuracies of 80%-90% in an entirely independent dataset of 240 patients, which were similar to those reached in the development set, evidencing the robustness of the algorithm against scanner, site, and protocol variations. 106 As the contrast-agent injection is part of clinical protocols and DSC is highly validated, research protocols commonly include DSC. This makes DSC datasets fairly available in glioma datasets.…”
Section: Radiomicsmentioning
confidence: 99%
“…In order to find the most suitable multi-task deep learning network (MTDL-Net), we compared Fast R-CNN ( 25 ), Faster R-CNN ( 26 ), Mask R-CNN ( 27 ) and RS-Net ( 28 ) for white matter segmentations and WMI status prediction. Based on the result of this ablation experiment (detailed in Supplementary Material ), we used Mask R-CNN as our MTDL-Net.…”
Section: Methodsmentioning
confidence: 99%
“…For differential diagnosis in brain cancer, numerous MRI-based machine learning approaches have been presented. These developments have partly been facilitated by the availability of several valuable public datasets, see for example the overviews in [141,92]. Most literature is dedicated to glioma characterisation, which is therefore discussed in more detail here.…”
Section: Methods Evaluation 21 State-of-the-art Methodology For Diagn...mentioning
confidence: 99%